Tirzepatide (Mounjaro, Zepbound, compounded) Tirzepatide dual GIP/GLP-1 mechanism produces robust weight loss and glycemic control, but the shorter half-life means slightly less flexibility in timing
Recovery from training improves
Rather than scavenging radicals on contact, it upregulates endogenous antioxidant enzyme systems at the gene expression level, including SOD, catalase, and glutathione peroxidase
L.PangM.-J.WongS.-J.TehL.-K.et al
We also explore the use of sodium-glucose co-transporter-2 (SGLT-2) inhibitors, amylin mimetics, leptin analogues, ghrelin antagonists and centrally acting agents to suppress appetite [neuropeptide Y (NPY) antagonists, melanocortin-4 receptor (MC4R) agonists and cannabinoid-1 receptor antagonists]